Geneva Capital Management LLC decreased its position in STERIS plc (NYSE:STE – Free Report) by 2.8% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 100,773 shares of the medical equipment provider’s stock after selling 2,861 shares during the period. Geneva Capital Management LLC owned 0.10% of STERIS worth $21,163,000 as of its most recent filing with the SEC.
Other hedge funds also recently made changes to their positions in the company. SGL Investment Advisors Inc. grew its holdings in STERIS by 1.1% during the 3rd quarter. SGL Investment Advisors Inc. now owns 11,713 shares of the medical equipment provider’s stock valued at $2,460,000 after buying an additional 130 shares in the last quarter. Phoenix Financial Ltd. raised its stake in STERIS by 11.0% in the third quarter. Phoenix Financial Ltd. now owns 1,152 shares of the medical equipment provider’s stock valued at $242,000 after purchasing an additional 114 shares in the last quarter. Diversified Trust Co raised its stake in STERIS by 64.4% in the third quarter. Diversified Trust Co now owns 7,084 shares of the medical equipment provider’s stock valued at $1,488,000 after purchasing an additional 2,775 shares in the last quarter. Allworth Financial LP lifted its position in STERIS by 32.6% during the third quarter. Allworth Financial LP now owns 2,443 shares of the medical equipment provider’s stock valued at $514,000 after purchasing an additional 600 shares during the last quarter. Finally, Fisher Asset Management LLC bought a new stake in STERIS during the third quarter valued at approximately $2,407,000. 94.69% of the stock is currently owned by institutional investors.
Insider Buying and Selling at STERIS
In other news, CFO Karen L. Burton sold 5,880 shares of the firm’s stock in a transaction dated Wednesday, November 11th. The stock was sold at an average price of $255.62, for a total transaction of $1,503,045.60. Following the transaction, the chief financial officer directly owned 12,956 shares of the company’s stock, valued at approximately $3,311,812.72. This trade represents a 31.22% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Mohsen Sohi sold 4,893 shares of the firm’s stock in a transaction dated Tuesday, November 10th. The shares were sold at an average price of $253.22, for a total value of $1,239,005.46. Following the transaction, the director directly owned 24,305 shares in the company, valued at $6,154,512.10. This trade represents a 16.76% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders own 1.12% of the company’s stock.
STERIS Trading Down 0.2%
STE stock opened at $263.76 on Monday. The company has a market capitalization of $25.61 billion, a PE ratio of 31.29 and a beta of 0.86. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.44 and a current ratio of 2.05. STERIS plc has a one year low of $195.14 and a one year high of $269.44. The company’s 50 day moving average price is $223.28 and its two-hundred day moving average price is $224.61.
STERIS (NYSE:STE – Get Free Report) last announced its quarterly earnings data on Wednesday, November 4th. The medical equipment provider reported $2.94 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.68 by $0.26. STERIS had a net margin of 13.41% and a return on equity of 14.80%. The company had revenue of $1.59 billion during the quarter, compared to analysts’ expectations of $1.56 billion. During the same quarter in the prior year, the company earned $2.47 EPS. The firm’s revenue was up 8.8% on a year-over-year basis. As a group, analysts predict that STERIS plc will post 11.46 earnings per share for the current fiscal year.
STERIS Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Thursday, December 17th. Shareholders of record on Tuesday, November 17th will be paid a $0.69 dividend. The ex-dividend date of this dividend is Tuesday, November 17th. This represents a $2.76 annualized dividend and a yield of 1.0%. STERIS’s payout ratio is currently 32.74%.
Analysts Set New Price Targets
STE has been the subject of a number of research reports. Piper Sandler reissued an “overweight” rating and issued a $275.00 price target (up from $270.00) on shares of STERIS in a research note on Friday, August 7th. Wall Street Zen upgraded shares of STERIS from a “buy” rating to a “strong-buy” rating in a research report on Saturday. Jefferies Financial Group raised shares of STERIS from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $232.00 to $305.00 in a report on Friday. Morgan Stanley raised shares of STERIS from an “overweight” rating to a “buy” rating in a report on Friday. Finally, Weiss Ratings upgraded shares of STERIS from a “hold (c)” rating to a “hold (c+)” rating in a research report on Monday, November 9th. Five investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $283.50.
Get Our Latest Analysis on STE
STERIS Profile
STERIS plc (NYSE: STE) provides infection prevention and procedural products and services for healthcare, pharmaceutical, research, and other industries. Its offerings include sterilizers, washers and other equipment used to clean and sterilize medical devices and surgical instruments, as well as products for operating rooms and endoscopy procedures. The company also provides equipment installation, maintenance, repair, and training, along with contract sterilization and laboratory testing services.
Further Reading
- Five stocks we like better than STERIS
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.
